DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
NDC 70748-104 · Lupin Pharmaceuticals, Inc.
Packages
70748-104-06 — 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70748-104-06)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
70710-1805 — sitagliptin and metformin hydrochloride, 70710-1806 — sitagliptin and metformin hydrochloride, 70710-1986 — Sitagliptin and Metformin Hydrochloride, 70710-1987 — Sitagliptin and Metformin Hydrochloride, 70710-2036 — sitagliptin and metformin hydrochloride, 70710-2037 — sitagliptin and metformin hydrochloride, 70710-2038 — sitagliptin and metformin hydrochloride, 70748-101 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 70748-102 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 70748-103 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 70748-105 — Dapagliflozin, 70748-106 — Dapagliflozin, 70771-1714 — Dapagliflozin, 70771-1715 — Dapagliflozin, 70771-1859 — Sitagliptin and Metformin Hydrochloride, 70771-1860 — Sitagliptin and Metformin Hydrochloride, 70771-1869 — Sitagliptin and Metformin Hydrochloride, 70771-1870 — Sitagliptin and Metformin Hydrochloride, 70771-1879 — sitagliptin and metformin hydrochloride, 70771-1880 — sitagliptin and metformin hydrochloride, +635 more
Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels